145 related articles for article (PubMed ID: 29277464)
1. Determination of Tedizolid susceptibility interpretive criteria for gram-positive pathogens according to clinical and laboratory standards institute guidelines.
Bensaci M; Flanagan S; Sandison T
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):214-220. PubMed ID: 29277464
[TBL] [Abstract][Full Text] [Related]
2. Activities of Tedizolid and Linezolid Determined by the Reference Broth Microdilution Method against 3,032 Gram-Positive Bacterial Isolates Collected in Asia-Pacific, Eastern Europe, and Latin American Countries in 2014.
Pfaller MA; Flamm RK; Jones RN; Farrell DJ; Mendes RE
Antimicrob Agents Chemother; 2016 Sep; 60(9):5393-9. PubMed ID: 27353270
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
Chen KH; Huang YT; Liao CH; Sheng WH; Hsueh PR
Antimicrob Agents Chemother; 2015 Oct; 59(10):6262-5. PubMed ID: 26248355
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
Barber KE; Smith JR; Raut A; Rybak MJ
J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Tedizolid against Enterococci and Staphylococci, Including
Singh KV; Arias CA; Murray BE
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670435
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of tedizolid and comparator agents against clinical Gram-positive isolates recovered from patients with cancer.
Rolston KVI; Reitzel R; Vargas-Cruz N; Shelburne SA; Raad II; Prince RA
Diagn Microbiol Infect Dis; 2018 Aug; 91(4):351-353. PubMed ID: 29661529
[TBL] [Abstract][Full Text] [Related]
7. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
Dowzicky MJ; Park CH
Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
[TBL] [Abstract][Full Text] [Related]
8. In Vitro activities of Tedizolid and comparator antimicrobial agents against clinical isolates of Staphylococcus aureus collected in 12 countries from 2014 to 2016.
Karlowsky JA; Hackel MA; Bouchillon SK; Alder J; Sahm DF
Diagn Microbiol Infect Dis; 2017 Oct; 89(2):151-157. PubMed ID: 28793964
[TBL] [Abstract][Full Text] [Related]
9. Use of linezolid susceptibility test results as a surrogate for the susceptibility of Gram-positive pathogens to tedizolid, a novel oxazolidinone.
Zurenko G; Bien P; Bensaci M; Patel HN; Thorne G
Ann Clin Microbiol Antimicrob; 2014 Sep; 13():46. PubMed ID: 25238753
[TBL] [Abstract][Full Text] [Related]
10. Comparative
Wang S; Li Y; Xue F; Liu J; Yang W; Zhang J; Glenschek-Sieberth M; Lyu Y
J Chemother; 2019 Oct; 31(6):313-319. PubMed ID: 31215343
[TBL] [Abstract][Full Text] [Related]
11. Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections.
Ferrández O; Urbina O; Grau S
Drug Des Devel Ther; 2017; 11():65-82. PubMed ID: 28053508
[TBL] [Abstract][Full Text] [Related]
12. Activity of tedizolid against gram-positive clinical isolates causing infections in Europe and surrounding areas (2014-2015).
Pfaller MA; Sader HS; Shortridge D; Castanheira M; Flamm RK; Mendes RE
J Chemother; 2019 Jul; 31(4):188-194. PubMed ID: 31079589
[TBL] [Abstract][Full Text] [Related]
13. Global in vitro activity of tigecycline and linezolid against Gram-positive organisms collected between 2004 and 2009.
Dowzicky MJ; Chmelařová E
Int J Antimicrob Agents; 2011 Jun; 37(6):562-6. PubMed ID: 21497066
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of tedizolid against Staphylococcus aureus and Streptococcus pneumoniae collected in 2013 and 2014 from sites in Latin American countries, Australia, New Zealand, and China.
Biedenbach DJ; Bouchillon SK; Johnson B; Alder J; Sahm DF
Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1933-1939. PubMed ID: 27677280
[TBL] [Abstract][Full Text] [Related]
15. Exploring the pharmacodynamic interactions between tedizolid and other orally bioavailable antimicrobials against Staphylococcus aureus and Staphylococcus epidermidis.
Werth BJ
J Antimicrob Chemother; 2017 May; 72(5):1410-1414. PubMed ID: 28158617
[TBL] [Abstract][Full Text] [Related]
16. Activity of linezolid and tedizolid against clinical isolates of methicillin-resistant and methicillin and linezolid resistant Staphylococcus aureus: an in vitro comparison.
Peñuelas M; Candel FJ; Lejarraga C; López-González L; Viñuela-Prieto JM; López de Mendoza D
Rev Esp Quimioter; 2016 Oct; 29(5):255-8. PubMed ID: 27374726
[TBL] [Abstract][Full Text] [Related]
17. Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA and Europe (2014-17).
Carvalhaes CG; Sader HS; Flamm RK; Mendes RE
J Antimicrob Chemother; 2019 Jul; 74(7):1928-1933. PubMed ID: 30932152
[TBL] [Abstract][Full Text] [Related]
18. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
Zhanel GG; Love R; Adam H; Golden A; Zelenitsky S; Schweizer F; Gorityala B; Lagacé-Wiens PR; Rubinstein E; Walkty A; Gin AS; Gilmour M; Hoban DJ; Lynch JP; Karlowsky JA
Drugs; 2015 Feb; 75(3):253-70. PubMed ID: 25673021
[TBL] [Abstract][Full Text] [Related]
19. Surveillance of tedizolid activity and resistance: In vitro susceptibility of Gram-positive pathogens collected over 5 years from the United States and Europe.
Bensaci M; Sahm D
Diagn Microbiol Infect Dis; 2017 Feb; 87(2):133-138. PubMed ID: 27866673
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded Staphylococcus aureus in the bone and joint infection setting.
Abad L; Tafani V; Tasse J; Josse J; Chidiac C; Lustig S; Ferry T; Diot A; Laurent F; Valour F
J Antimicrob Chemother; 2019 Mar; 74(3):625-632. PubMed ID: 30517641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
